Reid, J. Spence
Vanderkarr, Mollie
Ray, Bidusee
Chitnis, Abhishek
Holy, Chantal E.
Sparks, Charisse
Funding for this research was provided by:
Johnson & Johnson
Article History
Received: 29 July 2021
Accepted: 28 February 2022
First Online: 5 March 2022
Declarations
:
: All data in the PREMIER database being de-identified, the use of these data for this study is exempt from Institutional Review Board oversight as dictated by Title 45 Code of Federal Regulations, Part 46 of the United States, specifically 45 CFR 46.101(b)(4). All methods were carried out in accordance with relevant guidelines and regulations. Experimental protocols were drafted and approved by all co-authors and the Medical Devices Epidemiology research team within the Johnson & Johnson, prior to the conduct of the study.
: MV, AC, CEH, and CS are employees of Johnson & Johnson (JnJ) and own stock in the company. BR was a contractor with JnJ at the time of the study. JSR is a consultant for JnJ but holds no stock nor receives royalty payments.